Complement activation in multiple sclerosis plaques: an immunohistochemical analysis. - Wikidata - awgldk - TriplyDB

Complement activation in multiple sclerosis plaques: an immunohistochemical analysis.

Complement activation in multiple sclerosis plaques: an immunohistochemical analysis.

http://www.wikidata.org/entity/Q33722349

about

miRNAs Participate in MS Pathological Processes and Its Therapeutic Response Emerging and Novel Functions of Complement Protein C1q Nutrition facts in multiple sclerosis Proteomic analysis of cerebrospinal fluid for relapsing-remitting multiple sclerosis and clinically isolated syndrome Complementing the inflammasome.Stepchild or Prodigy? Neuroprotection in Multiple Sclerosis (MS) Research.Adipsin Is Associated with Multiple Sclerosis: A Follow-Up Study of Adipokines.Protein-Based Classifier to Predict Conversion from Clinically Isolated Syndrome to Multiple Sclerosis Complement is activated in progressive multiple sclerosis cortical grey matter lesions.Next generation transcriptomics and genomics elucidate biological complexity of microglia in health and disease.The role of complement in neurological and neuropsychiatric diseases.Axonal degeneration in multiple sclerosis: defining therapeutic targets by identifying the causes of pathology.Cell specificity dictates similarities in gene expression in multiple sclerosis, Parkinson's disease, and Alzheimer's disease.Complement regulation and kidney diseases: recent knowledge of the double-edged roles of complement activation in nephrology.Tissue microarray methodology identifies complement pathway activation and dysregulation in progressive multiple sclerosis.Calcineurin proteolysis in astrocytes: Implications for impaired synaptic function Complement C1q-C3-associated synaptic changes in multiple sclerosis hippocampus.Complement activation and expression during chronic relapsing experimental autoimmune encephalomyelitis in the Biozzi ABH mouse.Increase in NF-κB-sensitive miRNA-146a and miRNA-155 in multiple sclerosis (MS) and pro-inflammatory neurodegeneration.Therapeutic potential of curcumin for multiple sclerosis.Complement in the pathogenesis of Alzheimer's disease.The complement system as a biomarker of disease activity and response to treatment in multiple sclerosis.Gut dysbiosis breaks immunological tolerance toward the central nervous system during young adulthood.Multiple sclerosis: Serum anti-CNS autoantibodies.Antineutrophil Cytoplasmic Antibody and Multiple Sclerosis.Systemic inhibition of the membrane attack complex impedes neuroinflammation in chronic relapsing experimental autoimmune encephalomyelitis.Identification of brain antigens recognized by autoantibodies in experimental autoimmune encephalomyelitis-induced animals treated with etomoxir or interferon-β.Investigation of ischemic and demyelinating lesions by cerebral vasoreactivity based on transcranial Doppler sonography: a comparative study

P2860

Q26748774-F4A00C2A-395D-4742-A738-2475FA03A81B Q26801642-A2F6E906-7FE2-4AB8-80B7-30DFD27B42C4 Q26851247-C3FC7AF1-1472-4AB8-ADE5-9FB8A2B8D3B3 Q29030741-C1FD5F27-7854-41A1-B1A9-916D646D4F7B Q34501875-1BF507EC-2E75-4D64-89BF-28E5B8A5BBEF Q35902446-28BA8F15-E7C1-441E-9DE9-14D193BD74A2 Q36304666-7A7614B4-2E09-48DC-9D44-E4E06AA4AC4E Q36604126-6269F780-424F-46F8-BF71-2F100834F2BE Q37031176-B13CA3C6-0CF5-465F-A60C-B692D84DF90B Q38514940-0533AC91-4758-4AB5-A706-A7F76BDF7CE3 Q38590250-C421E13A-E943-4B8E-B630-0DB8EC05C43F Q38653397-C9401DF0-EC8F-45CD-B839-983656841D73 Q38675620-00BCA225-610E-4A10-9965-4F6162ED1504 Q39200048-5FE2732A-C0CE-4EF4-9CA9-15E53EC3B187 Q40134939-242CCA51-DEA6-45E8-B12F-5B7C14867C16 Q40741759-9A5852B5-D95E-47DB-B8E4-AAA42FAE1B3A Q41332646-68469BDC-A68A-40E8-B7B8-0B43712A68E3 Q41523081-60A40D4B-B6A9-418B-8937-197F7C211280 Q42245222-EFF32698-724A-4928-A379-4EEA369B2D1F Q47401912-D71D106A-06A9-4140-907A-DB8C4C85B142 Q47709505-72809805-97B9-4A09-9CB4-FEEA9D08C81B Q47715259-AF1726A7-0F7D-4C2E-B599-D6170373BBEC Q50097667-D383EF4B-D49B-40E0-B6F5-04699D6158CF Q52093620-409BEEEF-87FA-483F-A10B-9AE7C9D302DE Q55008912-8D42C248-E069-4E24-AD63-65F6F8E90469 Q55120072-E1EFF9BD-554C-499E-8C8A-E79AFC878902 Q55187995-42AC1F58-D353-43C5-BAED-5F601772CCE2 Q58750922-EB92154F-7A6F-4A00-8326-857CB70E6A58

P2860

Complement activation in multiple sclerosis plaques: an immunohistochemical analysis.

http://www.wikidata.org/entity/Q33722349

description

2014 nî lūn-bûn

@nan

2014 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Complement activation in multiple sclerosis plaques: an immunohistochemical analysis.

@ast

Complement activation in multiple sclerosis plaques: an immunohistochemical analysis.

@en

type

label

Complement activation in multiple sclerosis plaques: an immunohistochemical analysis.

@ast

Complement activation in multiple sclerosis plaques: an immunohistochemical analysis.

@en

prefLabel

Complement activation in multiple sclerosis plaques: an immunohistochemical analysis.

@ast

Complement activation in multiple sclerosis plaques: an immunohistochemical analysis.

@en

P1433

Q33722349-205F85F6-4C88-4BB6-995D-CD1403C0129A

P1476

Q33722349-19701E7B-3AD1-4C66-9C28-892B2DA5B3AC

P2093

Q33722349-22A1F3D2-7C2C-4630-BCB2-435301AACB5B

Q33722349-477E909F-38AE-4F54-AC54-C23ADC9E901E

Q33722349-494E4DEC-735F-472A-8533-4DF54B9FBD68

Q33722349-72E3BDF3-A7CF-4907-B420-886ED2DC0AC1

Q33722349-76FC545E-A5F8-4186-AB0B-B1D4446FAF9F

Q33722349-77E7E0E9-4A93-41A1-998B-FC7000392B37

Q33722349-CAE1AE3F-4D6C-4187-9CB1-FFA9662CB741

P2860

Q33722349-012AD6CA-3932-40F7-ACB9-A4FC718FD560

Q33722349-08180019-843E-4B68-A089-31981ADA6C6B

Q33722349-0D1A7B6A-E346-4495-91F6-95CBF544B59B

Q33722349-21115D46-DC00-4352-86F3-AC4EABB3DAF5

Q33722349-25160B90-99B7-4D70-A0D3-EC55866F0F1A

Q33722349-2A5C6453-1344-4FED-B31E-C3F3127E4C50

Q33722349-2BB484FA-5734-436B-893E-A883E810CDEE

Q33722349-2BD76C03-6FF2-483C-A3E8-7510B184E406

Q33722349-2DDD0915-1D3A-4885-94DD-AA7324E22666

Q33722349-3A0D8C37-5B2C-4707-B2DC-BF094623A4EE

P2888

Q33722349-FDE4229E-A2CA-4F06-9DF4-944F010FBA0F

P304

Q33722349-62729E65-B5F6-40FE-990C-B0C90D09EC35

P31

Q33722349-218A20F1-B3A4-4996-B231-ADB1EB8BE7AB

P356

Q33722349-E314ADB9-EB5D-4395-B7C8-F1FD051CF3E8

P478

Q33722349-FD0FAB62-0C58-446B-8C29-5FFB6C48BAAB

P50

Q33722349-2FD1364C-5F57-416E-969F-9B658BCAEAC3

Q33722349-A08D6B03-57A8-4623-8C6C-4EBDCACD52A8

P577

Q33722349-81BAD97D-58FE-4E71-B973-52C9281638DB

P5875

Q33722349-3AE169F2-05C5-4CB1-AC21-8D4B5B6034DE

P6179

Q33722349-03D1F7B7-79E3-4991-AE7E-2494E98641BE

P698

Q33722349-4D761929-5C0B-4099-902A-EA2E01CFF4F5

P921

Q33722349-36754E51-C929-41E6-80F6-E29470D0FAC7

Q33722349-FA05F1FD-6412-4914-89EE-CF1F85BEAADD

P932

Q33722349-6B09F750-A1F4-450F-9B9F-7A720E31BAE2

P356

P1433

Acta neuropathologica communications

P1476

Complement activation in multiple sclerosis plaques: an immunohistochemical analysis.

@en

P2093

Bethan Dancey

http://www.w3.org/2001/XMLSchema#string

Claire L Harris

http://www.w3.org/2001/XMLSchema#string

Gillian Ingram

http://www.w3.org/2001/XMLSchema#string

James W Neal

http://www.w3.org/2001/XMLSchema#string

Neil P Robertson

http://www.w3.org/2001/XMLSchema#string

Sam Loveless

http://www.w3.org/2001/XMLSchema#string

Svetlana Hakobyan

http://www.w3.org/2001/XMLSchema#string

P2860

Homogeneity of active demyelinating lesions in established multiple sclerosis

Astrocytes in multiple sclerosis: a product of their environment

Distinct patterns of multiple sclerosis pathology indicates heterogeneity on pathogenesis

The immunopathology of multiple sclerosis: an overview

Heterogeneity of multiple sclerosis lesions: implications for the pathogenesis of demyelination

Cerebrospinal fluid in the diagnosis of multiple sclerosis: a consensus report.

Recombinant complement receptor 2 radiolabeled with [99mTc(CO)3]+: a potential new radiopharmaceutical for imaging activated complement

Complement components of the innate immune system in health and disease in the CNS.

Impaired binding of the age-related macular degeneration-associated complement factor H 402H allotype to Bruch's membrane in human retina.

Multiple sclerosis: an immune or neurodegenerative disorder?

P2888

P304

53

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/2051-5960-2-53

http://www.w3.org/2001/XMLSchema#string

P478

2

http://www.w3.org/2001/XMLSchema#string

P50

Owain W. Howell

P577

2014-05-09T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

262777767

http://www.w3.org/2001/XMLSchema#string

P6179

1038923504

http://www.w3.org/2001/XMLSchema#string

P698

24887075

http://www.w3.org/2001/XMLSchema#string

P921

multiple sclerosis

immunohistochemistry

P932

4048455

http://www.w3.org/2001/XMLSchema#string